QCG
USNA icon

Quadrant Capital Group’s Usana Health Sciences USNA Stock Holding History

Quadrant Capital Group’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-618
Closed -$10.8K – 2525
2026
Q1 		$10.8K Sell
618
-924
-60% -$18.3K ﹤0.01% 2174
2025
Q4 		$30.3K Sell
1,542
-17,954
-92% -$372K ﹤0.01% 1847
2025
Q3 		$537K Sell
19,496
-515
-3% -$15.8K 0.02% 839
2025
Q2 		$611K Buy
20,011
+13,159
+192% +$374K 0.02% 749
2025
Q1 		$185K Buy
6,852
+6,279
+1,096% +$199K 0.01% 1337
2024
Q4 		$20.6K Buy
573
+82
+17% +$3.07K ﹤0.01% 1881
2024
Q3 		$18.6K Buy
491
+82
+20% +$3.37K ﹤0.01% 1926
2024
Q2 		$18.5K Buy
409
+44
+12% +$2.02K ﹤0.01% 1882
2024
Q1 		$17.7K Sell
365
-614
-63% -$30.1K ﹤0.01% 1897
2023
Q4 		$52.5K Sell
979
-635
-39% -$32.1K ﹤0.01% 1360
2023
Q3 		$94.6K Sell
1,614
-89
-5% -$5.57K 0.01% 904
2023
Q2 		$107K Sell
1,703
-312
-15% -$19.9K 0.01% 822
2023
Q1 		$127K Buy
2,015
+294
+17% +$17.5K 0.01% 711
2022
Q4 		$91.6K Buy
1,721
+772
+81% +$41.8K 0.01% 828
2022
Q3 		$53K Buy
949
+722
+318% +$47.7K 0.01% 1013
2022
Q2 		$16K Buy
227
+105
+86% +$7.82K ﹤0.01% 1425
2022
Q1 		$9K Buy
122
+101
+481% +$9.11K ﹤0.01% 1716
2021
Q4 		$2K Sell
21
-7
-25% -$698 ﹤0.01% 2191
2021
Q3 		$3K Buy
28
+14
+100% +$1.35K ﹤0.01% 2078
2021
Q2 		$1K Buy
14
+6
+75% +$602 ﹤0.01% 2336
2021
Q1 		$1K Hold
8
– – ﹤0.01% 2309
2020
Q4 		$1K Hold
8
– – ﹤0.01% 2206
2020
Q3 		$1K Hold
8
– – ﹤0.01% 2075
2020
Q2 		$1K Sell
8
-692
-99% -$54.3K ﹤0.01% 2144
2020
Q1 		$40K Hold
700
– – 0.01% 983
2019
Q4 		$54K Hold
700
– – 0.01% 1297
2019
Q3 		$47K Buy
+700
New +$47K 0.01% 1243

Other funds holding USNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Creative Planning
Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Quadrant Capital Group's USNA Position: Q2 2026 in Review

Quadrant Capital Group sold out of Usana Health Sciences (USNA) in Q2 2026, closing a stake of 618 shares — an estimated $10.8K sold.

Quadrant Capital Group first reported a position in USNA in Q3 2019 and held it in 27 quarters. The position peaked at $611K in Q2 2025. 138 funds tracked by Wall St. Rank hold USNA as of Q2 2026.

  • Quadrant Capital Group reported no remaining Usana Health Sciences position as of Q2 2026 after selling out during the quarter.
  • Quadrant Capital Group sold 618 Usana Health Sciences shares in Q2 2026, an estimated $10.8K.
  • Quadrant Capital Group first reported a position in Usana Health Sciences in Q3 2019 and held it in 27 quarters.
  • Quadrant Capital Group's Usana Health Sciences position peaked at $611K in Q2 2025.
  • 138 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2026.

Based on Quadrant Capital Group's 13F filing for Q2 2026, filed 14 Aug 2026.